期刊文献+

氯化锂对APP/PS1双转基因小鼠脑组织中β淀粉样蛋白含量的影响

Lithium Chloride Treatment Reduces the Content of β-Amyloid Peptide in Brain Tissues of APP/PS1 Double Transgenic Mice
下载PDF
导出
摘要 目的:探究氯化锂(LiCl)对APP/PS1双转基因小鼠脑组织中β-淀粉样肽(Aβ)含量的影响。方法:用PCR及琼脂糖电泳方法分选4月及8月龄野生型及APP/PS1双转基因小鼠,将小鼠分为野生型(WT)组、WT+Li组、APP/PS1组及APP/PS1+Li组4组(n=6),WT+Li组和APP/PS1+Li组小鼠采用LiCl灌胃2个月[100mg/(kg·d)],WT组及APP/PS1组采用等量生理盐水灌胃处理(试验检测时4组小鼠为6月及10月龄);采用免疫组织化学法检测6月及10月龄小鼠脑组织中老年斑数量,采用ELISA法测定小鼠脑组织内不可溶性Aβ含量。结果:灌胃结束时,与WT组小鼠比较,APP/PS1双转基因小鼠脑组织内老年斑数量、不可溶性Aβ含量均显著升高(P<0.05),10月龄小鼠更明显;与APP/PS1组小鼠比较,APP/PS1+Li组小鼠脑组织内老年斑数量及不可溶性Aβ含量显著降低,差异有统计学意义(P<0.05)。结论:LiCl可减少APP/PS1双转基因小鼠脑组织Aβ含量,这可能是其治疗精神性疾病的机制之一。 Objective:To investigate the effect of lithium chloride(LiCl)on the content ofβ-amyloid peptide(Aβ)in the brains of APP/PS1 double transgenic mice.Methods:Wild-type(WT)and APP/PS1 double transgenic mice at 4 and 8 months old were verified by genotyping.Experimental groups included WT group,WT+Li group,APP/PS1 group and APP/PS1+Li group.WT+Li group and APP/PS1+Li group were intragastrically administered with 100 mg/(kg·d)LiCl for 2 months,while WT group and APP/The PS1 group was treated with the same amount of normal saline.Senile plaques in the brain tissues of mice at 6 and 10 months old were detected by immunohistochemistry.The content of insoluble Aβin mouse brain tissue was determined by ELISA.Results:At the end of the treatment,,the numbers of senile plaques and insoluble Aβin APP/PS1 double transgenic mice were significantly increased when compared with WT group(P<0.05).Senile plaques and insoluble Aβwere more obvious in 10 months-old mice.Compared with APP/PS1 group,the number of senile plaques and the content of insoluble Aβwere significantly decreased in the brains of APP/PS1+Li group(P<0.05).Conclusion:LiCl treatment can reduce the Aβcontent in brain tissue of APP/PS1 double transgenic mice.It may be one of the mechanisms used in clinical treatment of mental diseases.
作者 向洁 曾晓晓 曹坤 董阳婷 徐毅 冉龙艳 邓婕 官志忠 XIANG Jie;ZENG Xiaoxiao;CAO Kun;DONG Yangting;XU Yi;RAN Longyan;DENG Jie;GUAN Zhizhong(Department of Pathology,the Affiliated Hospital of Guizhou Medical University,Guiyang 550004,Guizhou,China;Key Laboratory of Endemic and Ethnic Diseases of the Ministry of Education,Guizhou Medical University,Guiyang 550004,Guizhou,China;Key Laboratory of Medical Molecular Biology,Guizhou Medical University,Guiyang 550004,Guizhou,China)
出处 《贵州医科大学学报》 CAS 2019年第5期503-508,共6页 Journal of Guizhou Medical University
基金 国家自然科学基金(U1812403) 贵州省创新计划项目[黔教合协同创新中心(2014)06] 贵州省科技创新团队基金[黔科通(2016)161]
关键词 阿尔茨海默病 老年斑 APP/PS1双转基因小鼠 Β-淀粉样肽 氯化锂 免疫组织化学法 Alzheimer's disease senile plaque APP/PS1 double transgenic mice β-amyloid peptide lithium chloride immunohistochemistry
  • 相关文献

参考文献5

二级参考文献44

  • 1刘兰芬,赵贵芳,宋振铎,李传琦.碳酸锂对双相情感障碍的预防效果及相关因素分析[J].中国神经精神疾病杂志,1996,22(4):212-214. 被引量:9
  • 2沈其杰 陈学诗 陈秀华 主编.中国心境(情感)障碍研究40年进展[A].陈学诗,陈秀华,主编.中国现代神经精神病学发展概况[C].北京:中国科学技术出版社,1995.247-257.
  • 3Shorter E. The history of lithium therapy[J]. Bipolar Disord, 2009, 11( Suppl 2): 4-9.
  • 4Baldessarini R J, Tondo L, Davis P, et al. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review[J]. Bipolar Disord, 2006, 8(5 Pt 2): 625- 639.
  • 5Goodwin FK. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder[J]. J Clin Psychiatry, 2003, 64 (Suppl 5): 18-24.
  • 6Cipriani A, Pretty H, Hawton K, et al. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials[J]. Am J Psychiatry, 2005, 162(10): 1805- 1819.
  • 7Chuang, DM. The antiapoptotic actions of mood stabilizers:molecular mechanisms and therapeutic potentials[J]. Ann N Y Acad Sci, 2005, 1053: 195-204.
  • 8Goodwin, GM, Geddes JR. Latest maintenance data on lithium in bipolar disorder[J]. Eur Neuropsychopharmacol, 2003, 13 (Suppl 2): $51-$55.
  • 9Nierenberg AA, Friedman ES, Bowden CL, et al. Lithium treatment moderate-dose use study (LITMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium[J]. Am J Psychiatry, 2013, 170(1): 102-110.
  • 10Malhi GS, Tanious M, Das P, et al. Potential mechanisms of action of lithium in bipolar disorder. Current understanding[J]. CNS Drugs, 2013, 27(2): 135-153.

共引文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部